The bovine dialysable leukocyte extract IMMUNEPOTENT CRP induces immunogenic cell death in breast cancer cells leading to long-term antitumour memory

[1] Siegel RL(2019)Cancer statistics CA Cancer J. Clin. 69 7-34

[2] Miller KD(2019)Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer. Nat. Rev. Clin. Oncol. 16 296-311

[3] Jemal A(1973)Immunotherapy in breast cancer Panminerva Med 15 435-436

[4] Richman J(2013)Immunogenic cell death in cancer therapy Annu Rev. Immunol. 31 51-72

[5] Dowsett M(2017)Trial watch: immunogenic cell death induction by anticancer chemotherapeutics OncoImmunology 11 215-233

[6] Pederzini A(2012)The secret ally: Immunostimulation by anticancer drugs Nat. Rev. Drug Discov. 224 389-400

[7] Kroemer G(2011)In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival J. Pathol. 32 637-646

[8] Galluzzi L(2010)Antiangiogenic and antitumor effects of IMMUNEPOTENT CRP in murine melanoma Immunopharmacol. Immunotoxicol. 18 e7759-852

[9] Kepp O(2018)IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production BMC Cancer 7 844-458

[10] Zitvogel L(2019)Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines PeerJ 14 451-3250

[1] Siegel RL(2019)Cancer statistics CA Cancer J. Clin. 69 7-34

[2] Miller KD(2019)Beyond 5 years: enduring risk of recurrence in oestrogen receptor-positive breast cancer. Nat. Rev. Clin. Oncol. 16 296-311

[3] Jemal A(1973)Immunotherapy in breast cancer Panminerva Med 15 435-436

[4] Richman J(2013)Immunogenic cell death in cancer therapy Annu Rev. Immunol. 31 51-72

[5] Dowsett M(2017)Trial watch: immunogenic cell death induction by anticancer chemotherapeutics OncoImmunology 11 215-233

[6] Pederzini A(2012)The secret ally: Immunostimulation by anticancer drugs Nat. Rev. Drug Discov. 224 389-400

[7] Kroemer G(2011)In situ immune response after neoadjuvant chemotherapy for breast cancer predicts survival J. Pathol. 32 637-646

[8] Galluzzi L(2010)Antiangiogenic and antitumor effects of IMMUNEPOTENT CRP in murine melanoma Immunopharmacol. Immunotoxicol. 18 e7759-852

[9] Kepp O(2018)IMMUNEPOTENT CRP induces cell cycle arrest and caspase-independent regulated cell death in HeLa cells through reactive oxygen species production BMC Cancer 7 844-458

[10] Zitvogel L(2019)Cytotoxic activity of IMMUNEPOTENT CRP against non-small cell lung cancer cell lines PeerJ 14 451-3250